Fact Sheet: Patent Abuse

Sep 25, 2020

Prescription drug prices are out-of-control thanks to the anti-competitive tactics and price-gouging practices of Big Pharma. Despite an escalating crisis of affordability, made worse by the economic impact of the COVID-19 pandemic, brand name drug companies continue to engage in anti-competitive behavior and price-gouging tactics in order to keep prices high and pad their bottom lines.